Viewing Study NCT05863494



Ignite Creation Date: 2024-05-06 @ 7:01 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05863494
Status: RECRUITING
Last Update Posted: 2023-05-18
First Post: 2023-04-10

Brief Title: Transcranial Direct Current Stimulation and Chronic Pain
Sponsor: University of Arizona
Organization: University of Arizona

Study Overview

Official Title: Toward Personalized Treatment of Chronic Pain Using Transcranial Direct Current Stimulation Paired With Deep Learning
Status: RECRUITING
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: tDCS
Brief Summary: This clinical trial uses transcranial direct current stimulation tDCS using the patented tKIWI system to safely reduce self-reported chronic pain with little to no side effects to improve our understanding and ability to accurately diagnose pain disorders which would facilitate the development of pharmacologic and non-pharmacologic treatment modalities using deep learning architecture built into the tKIWI
Detailed Description: Pain is a severe and growing problem in the United States with more than 116 million Americans suffering from chronic pain and more than 635 billion is spent annually on pain and its related healthcare costs Additionally opioid addiction has become a national crisis with nearly 50000 deaths every year as a result of opioid-involved overdoses and nearly 785 billion spent annually on opioid misuse and addiction Currently available treatments for pain namely opioid analgesics have limited effectiveness and can lead to a significant number of side effects and complications including dependence pharmacodynamic tolerance sedation gastrointestinal issues respiratory depression immunosuppression and hormonal changes Effectively treating pain requires an accurate assessment of pain however current methods of diagnosing and evaluating pain depend on subjective self-reporting including the use of visual and numerical pain scales The subjective nature of describing pain makes it virtually impossible to quantify and therefore difficult to treat and monitor To overcome this subjectivity through a non-invasive neuromodulation technique called transcranial direct current stimulation tDCS and deep learning pain can be measured objectively using electroencephalograph EEG to assess and personalize treatment The overarching goal of this project is to apply transcranial direct current stimulation tDCS as an alternative to opioids for the reduction in chronic pain The investigators long-term goal is to use these data to analyze EEG signals and generate personalized tDCS treatment in real time

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None